Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan-Feb;5(1 Suppl 1):3-4.
doi: 10.1111/j.1524-6175.2003.02016.x.

Introduction: management of hypertension and cardiovascular risk factors in African Americans

Keith C Ferdinand  1
Affiliations

Introduction: management of hypertension and cardiovascular risk factors in African Americans

Keith C Ferdinand. J Clin Hypertens (Greenwich). 2003 Jan-Feb.
No abstract available

PubMed Disclaimer

References

    1. SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment of older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265:3255–3264. - PubMed
    1. Hypertension Detection and Follow‐Up Program Cooperative Group . Five‐year findings of the Hypertension Detection and Follow‐up Program: mortality by race, sex and blood pressure level. A further analysis. J Commun Health. 1984;9:314–327. - PubMed
    1. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA. 2001;285: 2719–2728. - PubMed
    1. Grimm RH, Margolis KL, Papademetriou V, et al. Baseline characteristics of participants in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2001;37:19–27. - PubMed
    1. Dahlof B, Devereaux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359:995–1003. - PubMed